Literature DB >> 19094005

Organ donation after circulatory determination of death: lessons and unresolved controversies.

James F Childress1.   

Abstract

This article responds to the four pieces in this special symposium of the Journal of Law, Medicine & Ethics on uncontrolled organ donation following circulatory death (uDCD). The response will focus on lessons and debates about the kinds of consent necessary and sufficient for temporary organ preservation in the context of DCD and for organ donation itself; on conflicts of obligation, loyalty, and interest in DCD and ways to address those conflicts; and on benefit, cost, risk assessments of uDCD programs, including measures to achieve a more favorable balance of benefits, costs, and risks.

Entities:  

Mesh:

Year:  2008        PMID: 19094005     DOI: 10.1111/j.1748-720X.2008.00336.x

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  4 in total

1.  Presumed consent for organ preservation in uncontrolled donation after cardiac death in the United States: a public policy with serious consequences.

Authors:  Joseph L Verheijde; Mohamed Y Rady; Joan McGregor
Journal:  Philos Ethics Humanit Med       Date:  2009-09-22       Impact factor: 2.464

2.  Donation after cardiocirculatory death: a call for a moratorium pending full public disclosure and fully informed consent.

Authors:  Ari R Joffe; Joe Carcillo; Natalie Anton; Allan deCaen; Yong Y Han; Michael J Bell; Frank A Maffei; John Sullivan; James Thomas; Gonzalo Garcia-Guerra
Journal:  Philos Ethics Humanit Med       Date:  2011-12-29       Impact factor: 2.464

3.  Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes.

Authors:  Iván Ortega-Deballon; Laura Hornby; Sam D Shemie
Journal:  Crit Care       Date:  2015-06-24       Impact factor: 9.097

4.  Organ donation after controlled cardiocirculatory death: confidence by clarity.

Authors:  Thomas Bein; Alain Combes; Geert Meyfroidt
Journal:  Intensive Care Med       Date:  2021-02-23       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.